20:31 , Jan 25, 2018 |  BC Innovations  |  Translation in Brief

Melanoma vs. melanoma

A Northwestern University team has discovered that some non-metastatic melanoma cells carry a signal, pigment epithelium derived factor (PEDF), that can induce immune-mediated killing of metastatic cells, pointing toward a new immunotherapeutic strategy for the...
08:00 , Nov 16, 2015 |  BioCentury  |  Emerging Company Profile

Bridge to POC

BRIM Biotechnology Inc. has assembled a team of translational science veterans to fill what it sees as a gap in Taiwanese drug development capabilities. The company plans to bring in preclinical projects with global commercialization...
07:00 , Jul 13, 2015 |  BC Week In Review  |  Company News

BRIM Biotechnology, J&J deal

Johnson & Johnson’s Janssen Pharmaceutica N.V. unit partnered with BRIM to develop and commercialize undisclosed preclinical compounds identified by J&J for dengue disease. The companies will move the compounds through clinical proof of concept, after...